Communiqués Eli Lilly and Company Berne S.E.

Actions

LLY

US5324571083

Temps Différé Berne S.E. Autres places de cotation 18:00:02 16/04/2024			Varia. 5j.	Varia. 1 janv.
684,5 ^CHF	-1,23%		-2,83%	+40,38%

12:51	L'EMA déclare que le CHMP a donné un avis positif sur le vaccin mResvia RSV mRNA pour la prévention chez les adultes de 60 ans et plus	RE
12:42	L'Inde prévoit des mesures d'incitation pour les fabricants de médicaments contre le diabète et l'obésité en 2026, selon un responsable gouvernemental	RE

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

TRexBio Announces Collaboration Partner Lilly Has Initiated a Phase 1 Study of TRB-051 for Autoimmune and Inflammatory Diseases	27/06	AQ
Augustine Therapeutics announces EUR17 million Series A1 financing round	27/06	AQ
Lilly collaborates with OpenAI to discover novel medicines to treat drug-resistant bacteria	25/06	PR
Lilly Declares Third-Quarter 2024 Dividend	24/06	PR
WHO and Eli Lilly caution patients against falling for fake versions of popular weight-loss drugs	20/06	AQ
Eli Lilly and : Lilly Warns Patients About Counterfeit and Compounded Medicines Releases Open Letter and Takes Further Legal Action Against Counterfeit, Fake, Unsafe, and Untested Products	20/06	PU
Eli Lilly and : An Open Letter From Eli Lilly and Company Regarding Certain Practices Related to Mounjaro® and Zepbound®	20/06	PU
Lilly's tirzepatide was superior to placebo for MASH resolution, and more than half of patients achieved improvement in fibrosis at 52 weeks	08/06	PR
Lilly announces departure of Anat Ashkenazi, chief financial officer	05/06	PR
Eli Lilly and Company - Melissa Seymour to join Lilly as executive vice president of Global Quality	05/06	AQ
Silo Pharma's (NASDAQ: SILO) Promising Developments and Key Insights for Traders and Investors	04/06	AQ
Eli Lilly and : Asco Lilly Oncology Presentation	03/06	PU
AKTIS ONCOLOGY NAMES TYLER BENEDUM, Ph.D., CHIEF TECHNICAL OFFICER	31/05	AQ
Lilly, UNICEF expand support to help millions of young people at risk of noncommunicable diseases	29/05	PR
NanoViricides (NNVC) Strengthens Drug Development Efforts with Calvert Labs Partnership and Announces Promising RSV Study Results	29/05	AQ
Lilly to Participate in Goldman Sachs 45th Annual Global Healthcare Conference	28/05	PR
Major manufacturing investment to support API production for tirzepatide	27/05	AQ
Eli Lilly beefs up plan to expand manufacturing for popular drugs Zepbound, Mounjaro	24/05	AQ
Eli Lilly and : 2015 Global Health Programs Report	24/05	PU
Lilly Increases Manufacturing Investment to $9 Billion at Newest Indiana Site to Boost API Production for Tirzepatide and Pipeline Medicines	24/05	PR

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

A la une

David Ricks, PDG d'Eli Lilly : Un marche de plus d'un milliard de personnes

Le 12 mars 2024 à 19:47